BRPI0811956A8 - Solução tópica não aquosa de diclofenaco e processo para sua preparação - Google Patents

Solução tópica não aquosa de diclofenaco e processo para sua preparação

Info

Publication number
BRPI0811956A8
BRPI0811956A8 BRPI0811956A BRPI0811956A BRPI0811956A8 BR PI0811956 A8 BRPI0811956 A8 BR PI0811956A8 BR PI0811956 A BRPI0811956 A BR PI0811956A BR PI0811956 A BRPI0811956 A BR PI0811956A BR PI0811956 A8 BRPI0811956 A8 BR PI0811956A8
Authority
BR
Brazil
Prior art keywords
preparation
aqueous
topical
solution
diclofenac solution
Prior art date
Application number
BRPI0811956A
Other languages
English (en)
Inventor
R Patel Ketan
Original Assignee
R Patel Ketan
Troikaa Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Patel Ketan, Troikaa Pharmaceuticals Ltd filed Critical R Patel Ketan
Publication of BRPI0811956A2 publication Critical patent/BRPI0811956A2/pt
Publication of BRPI0811956A8 publication Critical patent/BRPI0811956A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SOLUÇÃO TÓPICA NÃO AQUOSA DE DICLOFENACO E PROCESSO PARA SUA PREPARAÇÃO. Uma solução tópica não de sal de diclofenaco farmaceuticamente aceitável é divulgada. A composição da solução tópica não aquosa possui uma quantidade terapeuticamente eficaz de sal de diclofenaco e farmaceuticamente aceitável, solubilizante, intensificador da penetração e solvente e, opcionalmente, um umectante não irritante, um acelerador adicional da penetração e antioxidantes, bem como um processo para preparar os mesmos.
BRPI0811956A 2007-06-08 2008-06-09 Solução tópica não aquosa de diclofenaco e processo para sua preparação BRPI0811956A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1092MU2007 2007-06-08
PCT/IN2008/000363 WO2009047785A2 (en) 2007-06-08 2008-06-09 A non-aqueous topical solution of diclofenac and process for preparing the same

Publications (2)

Publication Number Publication Date
BRPI0811956A2 BRPI0811956A2 (pt) 2014-11-11
BRPI0811956A8 true BRPI0811956A8 (pt) 2015-09-22

Family

ID=40524886

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0811956A BRPI0811956A8 (pt) 2007-06-08 2008-06-09 Solução tópica não aquosa de diclofenaco e processo para sua preparação

Country Status (23)

Country Link
US (1) US10702469B2 (pt)
EP (1) EP2211837B1 (pt)
JP (2) JP5535066B2 (pt)
KR (1) KR101517494B1 (pt)
CN (1) CN101790370B (pt)
AP (1) AP3643A (pt)
AU (1) AU2008309170B2 (pt)
BR (1) BRPI0811956A8 (pt)
CA (1) CA2697458C (pt)
CO (1) CO6270203A2 (pt)
CU (1) CU23999B1 (pt)
DK (1) DK2211837T3 (pt)
EA (1) EA018119B1 (pt)
ES (1) ES2445443T3 (pt)
HK (1) HK1147066A1 (pt)
IL (1) IL202009A (pt)
MX (1) MX2009013352A (pt)
MY (1) MY151437A (pt)
PL (1) PL2211837T3 (pt)
PT (1) PT2211837E (pt)
UA (1) UA97529C2 (pt)
WO (1) WO2009047785A2 (pt)
ZA (1) ZA200908705B (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100099766A1 (en) * 2008-10-16 2010-04-22 Novartis Ag Topical NSAID compositions having sensate component
JP5650199B2 (ja) * 2009-04-10 2015-01-07 スピレイカー・インコーポレイテッドＳｐｉｒａｃｕｒ， Ｉｎｃ． 閉鎖された切開部用の陰圧閉鎖療法システムを取り付けるための方法および装置
US9308213B2 (en) 2010-10-29 2016-04-12 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US11202831B2 (en) 2010-10-29 2021-12-21 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US11730709B2 (en) 2010-10-29 2023-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US9744132B2 (en) 2010-10-29 2017-08-29 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US9504664B2 (en) 2010-10-29 2016-11-29 Infirst Healthcare Limited Compositions and methods for treating severe pain
US11224659B2 (en) 2010-10-29 2022-01-18 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US10695432B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US10695431B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US9737500B2 (en) 2010-10-29 2017-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US8895536B2 (en) 2010-10-29 2014-11-25 Infirst Healthcare Ltd. Compositions and methods for treating chronic inflammation and inflammatory diseases
US9271950B2 (en) 2010-10-29 2016-03-01 Infirst Healthcare Limited Compositions for treating chronic inflammation and inflammatory diseases
ITMI20121205A1 (it) 2012-07-11 2014-01-12 Glycores 2000 Srl Composizione con attivita' antinfiammatoria ed analgesica da somministrare per uso esterno mediante vaporizzazione
JP2014152172A (ja) * 2013-02-08 2014-08-25 Daiya Seiyaku Kk 清涼感付与外用組成物、清涼感付与貼付剤、清涼感付与方法、清涼感付与外用組成物の製造方法、及び、清涼感付与貼付剤の製造方法
CN114903848A (zh) * 2013-02-27 2022-08-16 阿根塔创新有限公司 透皮制剂
JP6738120B2 (ja) * 2013-03-29 2020-08-12 小林製薬株式会社 外用医薬組成物
JP6580306B2 (ja) * 2014-03-30 2019-09-25 小林製薬株式会社 外用医薬組成物
JP6599083B2 (ja) * 2014-03-30 2019-10-30 小林製薬株式会社 外用医薬組成物
JP6580305B2 (ja) * 2014-03-30 2019-09-25 小林製薬株式会社 外用医薬組成物
JP2019510824A (ja) * 2016-03-31 2019-04-18 スマーテック・トピカル・インコーポレイテッドＳＭＡＲＴＥＣＨ ＴＯＰＩＣＡＬ，Ｉｎｃ． 送達システム
CA3055159A1 (en) * 2017-03-07 2018-09-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Topical delivery systems for active compounds
JP2018030893A (ja) * 2017-11-14 2018-03-01 ダイヤ製薬株式会社 清涼感付与外用組成物の製造方法及び清涼感付与貼付剤の製造方法
CA3155267A1 (en) 2019-11-06 2021-05-14 Thomas Hnat Topical formulations of cyclooxygenase inhibitors and their use
JP2022096997A (ja) * 2020-12-18 2022-06-30 小林製薬株式会社 外用医薬組成物
WO2023180792A1 (en) 2022-03-25 2023-09-28 Glycores 2000 Srl Topical pharmaceutical composition with anti-inflammatory and analgesic activity and uses thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4353896A (en) 1981-06-08 1982-10-12 Levy Michael A Penetrating topical medicament
US4933184A (en) * 1983-12-22 1990-06-12 American Home Products Corp. (Del) Menthol enhancement of transdermal drug delivery
CA1236029A (en) * 1984-05-14 1988-05-03 Edmund Sandborn Pharmaceutical solutions comprising dimethyl sulfoxide
DE3522550A1 (de) 1985-06-24 1987-01-02 Klinge Co Chem Pharm Fab Aufspruehbare pharmazeutische zubereitung fuer die topische anwendung
US5093133A (en) 1990-01-24 1992-03-03 Mcneil-Ppc, Inc. Method for percutaneous delivery of ibuprofen using hydroalcoholic gel
US5318960A (en) 1992-06-03 1994-06-07 Frank Toppo System for transdermal delivery of pain relieving substances
US5985860A (en) 1992-06-03 1999-11-16 Toppo; Frank System for transdermal delivery of pain relieving substances
US5665378A (en) * 1994-09-30 1997-09-09 Davis; Roosevelt Transdermal therapeutic formulation
US5654337A (en) 1995-03-24 1997-08-05 II William Scott Snyder Topical formulation for local delivery of a pharmaceutically active agent
US5968542A (en) * 1995-06-07 1999-10-19 Southern Biosystems, Inc. High viscosity liquid controlled delivery system as a device
US7833543B2 (en) * 1995-06-07 2010-11-16 Durect Corporation High viscosity liquid controlled delivery system and medical or surgical device
EP0879597A4 (en) 1996-02-07 2001-01-31 Tsumura & Co TRANSPARENT AQUEOUS SOLUTION OF DICLOFENAC SODIUM, MEDICINAL COMPOSITIONS, AND USES
DE19725615A1 (de) 1997-06-17 1998-12-24 Permamed Ag Zur topischen Applikation bestimmte Diclofenac-Lösung
US5976566A (en) * 1997-08-29 1999-11-02 Macrochem Corporation Non-steroidal antiinflammtory drug formulations for topical application to the skin
US6193996B1 (en) * 1998-04-02 2001-02-27 3M Innovative Properties Company Device for the transdermal delivery of diclofenac
CH693625A5 (it) * 1999-02-18 2003-11-28 Inpharma Sa Composizioni farmaceutiche contenenti composti ad attività promotrice di assorbimento di principi attivi.
ATE464887T1 (de) * 2001-05-31 2010-05-15 Hisamitsu Pharmaceutical Co Perkutan resorbierbare pflaster
US20070196453A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs
CN102225046A (zh) * 2005-08-05 2011-10-26 努沃研究公司 透皮释药剂型

Also Published As

Publication number Publication date
CN101790370B (zh) 2013-06-12
JP5535066B2 (ja) 2014-07-02
JP2014098046A (ja) 2014-05-29
WO2009047785A9 (en) 2010-03-11
EA200971099A1 (ru) 2010-06-30
AP2010005169A0 (en) 2010-02-28
KR20100047840A (ko) 2010-05-10
EP2211837B1 (en) 2013-11-13
PL2211837T3 (pl) 2014-05-30
UA97529C2 (ru) 2012-02-27
PT2211837E (pt) 2014-02-17
CA2697458C (en) 2016-02-09
ZA200908705B (en) 2010-08-25
WO2009047785A3 (en) 2009-07-02
JP5734479B2 (ja) 2015-06-17
CO6270203A2 (es) 2011-04-20
CU23999B1 (es) 2014-06-27
EP2211837A2 (en) 2010-08-04
WO2009047785A2 (en) 2009-04-16
AP3643A (en) 2016-03-16
US10702469B2 (en) 2020-07-07
ES2445443T3 (es) 2014-03-03
AU2008309170A1 (en) 2009-04-16
BRPI0811956A2 (pt) 2014-11-11
IL202009A0 (en) 2010-06-16
EA018119B1 (ru) 2013-05-30
HK1147066A1 (en) 2011-07-29
MY151437A (en) 2014-05-30
DK2211837T3 (da) 2014-02-10
CU20090206A7 (es) 2011-09-21
US20100120918A1 (en) 2010-05-13
MX2009013352A (es) 2010-05-21
IL202009A (en) 2015-10-29
CA2697458A1 (en) 2009-04-16
CN101790370A (zh) 2010-07-28
AU2008309170B2 (en) 2013-03-14
KR101517494B1 (ko) 2015-05-04
JP2010529110A (ja) 2010-08-26

Similar Documents

Publication Publication Date Title
BRPI0811956A8 (pt) Solução tópica não aquosa de diclofenaco e processo para sua preparação
BR112012026767A2 (pt) composto, sal farmaceuticamente aceitável de um composto, composição farmacêutica, método para tratar ou previnir distúrbios, e, uso de um composto ou sal
BRPI0721905B8 (pt) composto inibidor de proteassoma, sua composição farmacêutica e seu uso
BR112015031903A8 (pt) composto, sal farmaceuticamente aceitável, composição farmacêutica e uso de um composto
EA201592256A1 (ru) Производные имидазопирролидинона и их применение при лечении заболеваний
BRPI0712631B8 (pt) compostos, processos para a preparação de um composto, composição farmacêutica, uso de um composto e combinações
EA201390840A1 (ru) Полициклический lpaантагонист и его применение
BR112013000920A2 (pt) compostos para a redução de produção de beta-amiloide
EA201200763A1 (ru) Замещенные производные карбамоилметиламиноуксусной кислоты в качестве новых ингибиторов nep
GT200500360A (es) Compuestos organicos
EA201100750A1 (ru) Замещенные диоксопиперидинилфталимидные производные
RS54470B1 (en) Catecholamine derivatives useful for the treatment of Parkinson's disease
GT201200164A (es) "nuevos compuestos de espiropiperidina"
BRPI0906444B8 (pt) compostos de 4-piridinona, composição farmacêutica que os compreende, bem como uso dos mesmos
MY162499A (en) Methylphenidate-prodrugs, processes of making and using the same
CR20110318A (es) Compuestos, composición farmacéutica y métodos para utilizarse en el tratamiento de trastornos metabólicos
BR112013019256A2 (pt) inibição de il-17 e ifn-gama para o tratamento de inflamação autoimune
EA201591499A1 (ru) Замещенные бисфенилбутановые производные фосфоновой кислоты в качестве ингибиторов nep (нейтральная эндопептидаза)
MX2011009709A (es) Compuestos para el tratamiento de la inflamacion y del dolor.
CL2011000341A1 (es) Compuestos derivados de pirrolidinona sustituida, moduladores de la actividad de ar para la inhibicion de ntd; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento de cancer, acne, hirsutismo, entre otras.
BR112013031146A2 (pt) liberação direcionada de compostos retinóides para as glândulas sebáceas
CO6321280A2 (es) Nueva clase espiro piperidinas para el tratamiento de enfermedades neurodegenerativas
ECSP077306A (es) Derivados de alquiliden-tetrahidronaftaleno, procedimiento para su preparación y su uso como antiinflamatorios
CL2011001829A1 (es) 3'-n-desmetil-4''-o-(2-dietilaminoetanoil)-6-o-metil-9a-aza-9a-homoeritromicina a, sus sales y formas cristalinas 1, 2 y 3; proceso de preparacion; uso para tratar enfermedades inflamatorias; composicion farmaceutica; y composicion que ademas comprende otro compuesto activo.
CL2008001325A1 (es) Compuestos derivados de pirazol-piridinona; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que los comprende; y su uso para tratar inflamacion, enfermedad de paget, osteoartritis, alzheimer, entre otras enfermedades.

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: TROIKAA PHARMACEUTICALS LTD (IN)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]